Online citations, reference lists, and bibliographies.

Osteoporosis And Polypharmacy

M Gosch, Michael Jeske, Christian Kammerlander, Tobias Roth
Published 2012 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
Osteoporosis is very common in elderly patients. Despite the severe health-related consequences for individual patients and the socioeconomic costs caused by osteoporotic fractures, treatment rates are still low. Due to drug interactions and patient compliance, polypharmacy is often mentioned as a reason for undertreatment. Several drugs have a direct or indirect effect on bone metabolism. The present paper discusses the risk of interactions of anti-osteoporotic drugs (oral and parenteral bisphosphonates, raloxifene, strontium ranelate, teriparatide, and denosumab) with other common medications in elderly patients and their impact on bone metabolism and fracture risk. In summary, the number and risk of drug interactions of all common anti-osteoporotic drugs are small and clinically rather irrelevant. However, patients with a polypharmacy are at a higher risk of fractures and should receive osteoporosis treatment, if indicated.ZusammenfassungOsteoporose hat eine hohe Prävalenz bei älteren Patienten. Trotz der enormen individuellen Folgen für die Betroffenen und die hohen sozioökonomischen Kosten osteoporotischer Frakturen sind die Therapieraten weiterhin sehr gering. Als Begründung wird immer wieder die Polypharmazie genannt, insbesondere im Hinblick auf mögliche Medikamenteninteraktionen sowie die Compliance. Zahlreiche Medikamente haben einen direkten oder indirekten Einfluss auf den Knochenmetabolismus. Im vorliegenden Review wird die Bedeutung möglicher Interaktionen diskutiert sowie das Frakturrisiko im Rahmen einer Polypharmazie dargestellt. Einerseits zeigt sich, dass das Interaktionspotenzial der zugelassenen Osteoporosemedikamente gering ist. Andererseits haben Patienten mit einer Polypharmazie ein erhöhtes Frakturrisiko und sollten eine Osteoporosetherapie erhalten, wenn diese indiziert ist.
This paper references
[Are statins of value in therapy of osteoporosis?].
M Gosch (2003)
10.1359/jbmr.060508
Effect of an aromatase inhibitor on bmd and bone turnover markers: 2-year results of the Anastrozole, Tamoxifen, Alone or in Combination (ATAC) trial (18233230).
Richard Eastell (2006)
10.1007/BF01116615
Modularity of osteoclast behaviour and “mode-specific” inhibition of osteoclast function
M. Zaidi (1990)
10.1016/0002-9378(93)90378-V
Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin.
T C Dahlman (1993)
10.1055/s-0037-1612970
Postpartum bone mineral density in women treated for thromboprophylaxis with unfractionated heparin or LMW heparin.
Ville Pettilä (2002)
10.1001/archinte.167.2.188
Effect of selective serotonin reuptake inhibitors on the risk of fracture.
J. Brent Richards (2007)
10.1530/eje.0.1300350
Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: a meta-analysis.
J. Faber (1994)
10.1024/0040-5930.64.5.292a
Osteoporose. Prävention – Diagnostik – Therapie
Reiner Bartl (2007)
10.1016/j.amjmed.2005.02.007
Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial.
M. B. O'Connell (2005)
10.1038/ajg.2008.87
Cumulative H. pylori Eradication Rates in Clinical Practice by Adopting First and Second-Line Regimens Proposed by the Maastricht III Consensus and a Third-Line Empirical Regimen
T. Rokkas (2009)
10.1517/13543784.17.9.1281
The effect of β-blockers on bone metabolism as potential drugs under investigation for osteoporosis and fracture healing
Simon Matthew Graham (2008)
10.1001/archinte.166.2.241
Risk of osteoporotic fracture in elderly patients taking warfarin: results from the National Registry of Atrial Fibrillation 2.
B. Gage (2006)
10.1001/archinternmed.2009.357
Meta-analysis of the impact of 9 medication classes on falls in elderly persons.
John C. Woolcott (2009)
10.1016/j.bone.2009.07.083
Effects of selective serotonin reuptake inhibitors on bone health in adults: time for recommendations about screening, prevention and management?
Elizabeth M Haney (2010)
10.1007/s00198-006-0206-y
Epidemiology, treatment and costs of osteoporosis in Germany—the BoneEVA Study
B. Häussler (2006)
10.1080/07315724.1995.10718522
Hypochlorhydria from short-term omeprazole treatment does not inhibit intestinal absorption of calcium, phosphorus, magnesium or zinc from food in humans.
C. Serfaty-Lacrosniere (1995)
10.1007/s00198-007-0477-y
Skeletal consequences of thiazolidinedione therapy
A. Grey (2007)
10.7326/0003-4819-133-7-200010030-00010
Low-Dose Hydrochlorothiazide and Preservation of Bone Mineral Density in Older Adults
A. LaCroix (2000)
10.1517/13543784.17.9.1281
The effect of beta-blockers on bone metabolism as potential drugs under investigation for osteoporosis and fracture healing.
Simon Matthew Graham (2008)
10.1007/s00393-010-0605-5
[Drug-induced osteopathies. Drugs, pathogenesis, forms, diagnosis, prevention and therapy].
Reiner Bartl (2010)
10.1007/s00198-010-1402-3
Surgery for fragility hip fracture—streamlining the process
Frankie Kl Leung (2010)
Epidemiolo - gy , treatment and costs of osteoporosis in Germanythe BoneEVA Study
B Häussler (2007)
[Drug-induced osteopathies].
Renato Javier (1999)
10.1111/j.1532-5415.2010.02769.x
Missed opportunities for osteoporosis treatment in patients hospitalized for hip fracture.
Lee A Jennings (2010)
10.7326/0003-4819-139-2-200307150-00009
Statin Use, Clinical Fracture, and Bone Density in Postmenopausal Women: Results from the Women's Health Initiative Observational Study
A. LaCroix (2003)
10.1111/J.1365-2125.2007.02961.X
Relationship between polypharmacy and underprescribing.
Mascha A J Kuijpers (2008)
10.1517/14728222.9.5.931
The role of the sympathetic nervous system in controlling bone metabolism
A. Togari (2005)
10.1001/archinte.1990.00390230093012
Determinants of vertebral mineral density in patients receiving long-term glucocorticoid therapy.
Ian R. Reid (1990)
10.1111/j.1365-2265.1992.tb01480.x
Morbidity in patients on L-thyroxine: a comparison of those with a normal TSH to those with a suppressed TSH.
Graham P. Leese (1992)
10.1038/ajg.2009.48
Proton Pump Inhibitors and Bone Fractures?
Loren Laine (2009)
10.2169/INTERNALMEDICINE.50.5266
Management and treatment of osteoporosis in patients receiving long-term glucocorticoid treatment: current status of adherence to clinical guidelines and related factors.
Daijun Kirigaya (2011)
10.1359/jbmr.0301214
Beta-adrenergic blockers reduce the risk of fracture partly by increasing bone mineral density: Geelong Osteoporosis Study.
J. Pasco (2004)
10.7326/0003-4819-115-1-1
Diuretic drug use and the risk for hip fracture.
Fred E. Heidrich (1991)
10.1001/archinte.168.8.820
Use of thiazolidinediones and fracture risk.
C. Meier (2008)
10.2165/11596510-000000000-00000
Cardiovascular, Ocular and Bone Adverse Reactions Associated with Thiazolidinediones
D. Motola (2012)
10.1007/s00402-011-1313-6
Long-term functional outcome in geriatric hip fracture patients
Christian Kammerlander (2011)
10.1007/s001980200108
The Epidemiology of Corticosteroid-Induced Osteoporosis: a Meta-analysis
T. Staa (2002)
10.1007/s00198-011-1692-0
Effects of paracetamol, non-steroidal anti-inflammatory drugs, acetylsalicylic acid, and opioids on bone mineral density and risk of fracture: results of the Danish Osteoporosis Prevention Study (DOPS)
Peter Vestergaard (2011)
A Randomized Double-blind Placebo-controlled Trial
J. Smith (2004)
10.1007/s00198-012-1939-4
Vitamin K supplementation for the primary prevention of osteoporotic fractures: is it cost-effective and is future research warranted?
Olga Gajić-Veljanoski (2012)
10.1001/jama.296.24.2947
Long-term proton pump inhibitor therapy and risk of hip fracture.
Yu-Xiao Yang (2006)
Epidemi - ologie der Stürze Älterer
C Becker (1999)
10.1007/s00198-010-1381-4
Predictors of very low adherence with medications for osteoporosis: towards development of a clinical prediction rule
D. H. Solomon (2010)
10.1093/ageing/29.1.35
Contribution of adverse drug reactions to hospital admission of older patients.
C K Mannesse (2000)
10.1046/j.1563-258X.2003.03030.x
Haben Statine einen Stellenwert in der Osteoporosetherapie
M Gosch (2003)
10.1055/S-2008-1039375
[Epidemiology of accidental falls in the elderly].
Clemens Becker (1999)
10.1007/s00391-011-0254-6
Treatment of osteoporosis in postmenopausal hip fracture patients after geriatric rehabilitation
Markus Gosch (2011)
10.1016/S0140-6736(05)67036-5
Adjuvant aromatase inhibitors for breast cancer
A Howell (2005)
10.1196/annals.1346.014
M-CSF, c-Fms, and signaling in osteoclasts and their precursors.
Frederick Ross (2006)
10.1016/j.bbalip.2007.03.006
PPARγ in human and mouse physiology
Sami Heikkinen (2007)
PPARgamma in human and mouse physiology.
S. Heikkinen (2007)
10.1111/j.1532-5415.2009.02195.x
Loop diuretic use and rates of hip bone loss and risk of falls and fractures in older women.
Lionel S. Lim (2009)
M - CSF , cFms , and signaling in osteoclasts and their precursors
FP Ross (2006)
10.1001/archinternmed.2010.94
Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the Women's Health Initiative.
S. Gray (2010)
10.1001/archinte.167.12.1246
Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men.
E. Haney (2007)
10.1093/oxfordjournals.qjmed.a069112
Decreased axial and peripheral bone density in patients taking long-term warfarin.
W. Philip (1995)
10.1016/S0002-9378(94)70299-3
A prospective study of heparin-induced osteoporosis in pregnancy using bone densitometry.
Linda A Barbour (1994)
10.1359/JBMR.051003
Loop diuretics increase bone turnover and decrease BMD in osteopenic postmenopausal women: results from a randomized controlled study with bumetanide.
Lars Rejnmark (2006)
10.1016/j.bone.2010.06.006
Use of antidepressant drugs and risk of osteoporotic and non-osteoporotic fractures.
B. M. Verdel (2010)
10.1111/j.1365-2125.2006.02831.x
Is inappropriate medication use a major cause of adverse drug reactions in the elderly?
M. Laroche (2007)
10.2337/dc07-2270
Rosiglitazone-Associated Fractures in Type 2 Diabetes
S. Kahn (2008)



This paper is referenced by
10.4212/CJHP.V69I1.1518
Bisphosphonates for Osteoporosis in Patients with Renal Insufficiency: Pharmacists' Practices and Beliefs.
Cheryl A. Sadowski (2016)
10.1007/s11657-015-0217-4
Factors affecting bone mineral density in postmenopausal women
Behzad Heidari (2015)
10.1007/s00108-014-3468-z
Alter und Osteoporose
Fabian Jakob (2014)
10.1007/978-1-4939-1637-5_35
35 Laparoscopic Malabsorption Procedures: Management of Nutritional Complications After Biliopancreatic Diversion
Fady Moustarah (2015)
10.4274/TOD.96720
Polypharmacy in Osteoporosis Patients
Yavuz Ali Karahan (2015)
10.1016/j.jgo.2014.08.004
Development and validation of a prognostic index for fracture risk in older men undergoing prostate cancer treatment.
Tisheeka R Graham-Steed (2014)
10.15210/JONAH.V7I1.8884
Implicações da polimedicação em idosos portadores de osteoporose
Edivaldo Cremer (2017)
10.1007/s11914-012-0121-4
Brains, Bones, and Aging: Psychotropic Medications and Bone Health Among Older Adults
M. Brown (2012)
10.1016/j.bone.2020.115405
Cortical thickness relative to the transverse diameter of third metacarpal bone reflects bone mineral density in patients with rheumatoid arthritis.
Ichiro Yoshii (2020)
10.1016/j.afos.2020.04.002
Rheumatoid arthritis in tight disease control is no longer risk of bone mineral density loss
Ichiro Yoshii (2020)
10.3390/nu10070922
Long-Term Dietary Intake of Chia Seed Is Associated with Increased Bone Mineral Content and Improved Hepatic and Intestinal Morphology in Sprague-Dawley Rats
Evelyn M Montes Chañi (2018)
10.1007/s40261-018-0716-3
The Association between Polypharmacy and Hip Fracture in Osteoporotic Women: A Nested Case–Control Study in South Korea
Hae-Young Park (2018)
10.1007/s00391-019-01569-5
Osteoporose und Multimorbidität
Susanne Wicklein (2019)
10.1007/s00198-018-4759-3
A systematic review of factors affecting medication adherence among patients with osteoporosis
Cheng Teng Yeam (2018)
Bone strength, load tolerance and injury risk in elite Australian football
Nicolas H Hart (2015)
Semantic Scholar Logo Some data provided by SemanticScholar